Dasatinib-Induced Hypopigmentation in Pediatric Patient with Chronic Myeloid Leukemia: A Case Report and Review of the Literature

Dasatinib-Induced Hypopigmentation in Pediatric Patient with Chronic Myeloid Leukemia: A Case Report and Review of the Literature

Dasatinib is an oral second-generation multitarget tyrosine-kinase inhibitor (TKI) that is efficacious in treating imatinib-resistant chronic myeloid leukemia (CML) or intolerant cases. Noncutaneous adverse effects with dasatinib are well known in the literature, most commonly cytopenias and fluid r...

Full description

Saved in:
Bibliographic Details
Main Authors: Bader Alharbi, Samer Alamri, Ahmed Mahdi, Siham Marghalani
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Dermatological Medicine
Online Access:http://dx.doi.org/10.1155/2018/4062431
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items